MOS
UTHR icon

MGO One Seven’s United Therapeutics UTHR Stock Holding History

MGO One Seven’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
912
+4
+0.4% +$2.25K 0.01% 977
2026
Q1 		$538K Buy
+908
New +$452K 0.01% 880
2019
Q1 		– Sell
-11
Closed -$1K – 1580
2018
Q4 		$1K Buy
+11
New +$1.27K ﹤0.01% 1733
2018
Q1 		$1K Hold
11
– – ﹤0.01% 1720
2017
Q4 		$2K Buy
+11
New +$1.4K ﹤0.01% 1552

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MGO One Seven's UTHR Position: Q2 2026 in Review

MGO One Seven increased its United Therapeutics (UTHR) stake by 0.44% in Q2 2026, buying an estimated $2.25K and bringing the position to 912 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #977.

MGO One Seven first reported a position in UTHR in Q4 2017 and has held it in 5 quarters since. The position peaked at $538K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • MGO One Seven held 912 shares of United Therapeutics worth $494K as of Q2 2026.
  • MGO One Seven bought 4 United Therapeutics shares in Q2 2026, an estimated $2.25K.
  • United Therapeutics made up 0.01% of MGO One Seven's portfolio in Q2 2026, its #977 holding.
  • MGO One Seven first reported a position in United Therapeutics in Q4 2017 and has held it in 5 quarters since.
  • MGO One Seven's United Therapeutics position peaked at $538K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.